KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 20, 2019
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2019-06-19+60,000→ 60,000 totalExercise: $2.78From: 2020-06-19Exp: 2029-06-19→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F2]25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.